» Articles » PMID: 16721824

Amyloid Beta Oligomerization is Induced by Brain Lipid Rafts

Overview
Journal J Cell Biochem
Date 2006 May 25
PMID 16721824
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Detergent-resistant lipid rafts are required for the generation of Abeta as they concentrate not only amyloid precursor protein (APP), but also the beta- and gamma-secretase that convert APP to Abeta. Recently, Abeta has been shown to be oligomerized, which results in neuronal cytotoxicity and synaptic failure. In this study, we have demonstrated that Abeta oligomers appeared immediately after the incubation of Abeta with lipid rafts isolated from the brain tissues of rats, and were converted into few Abeta fibrils, even after longer periods of incubation. The oligomerization of Abeta was not abolished after the brain lipid rafts were treated with heat, or with protease K, implying that the lipid raft proteins were determined not to be prerequisites for Abeta oligomerization. The cholesterol present in the lipid rafts might not be essential to Abeta oligomerization because Abeta oligomerization was not prevented after the cholesterol was removed from the lipid rafts with methyl-beta-cyclodextrin (MbetaCD). The Abeta oligomerization was accelerated by the application of lipid rafts isolated from ganglioside-rich cells, C2C12 cells, whereas this was not observed with the lipid rafts isolated from ganglioside-poor cells SK-N-MC and HeLa cells. In addition, lipid raft-induced Abeta oligomerization was shown to be inhibited in CHO-K1 cells which were defective with regard to ganglioside biosynthesis. This indicates that Abeta oligomerization requires gangliosides that are enriched in the lipid rafts.

Citing Articles

Protective effect of trehalose sugar on amyloid-membrane interactions using BLM electrophysiology.

Xu Y, Filice C, Leonenko Z Biophys J. 2024; 123(12):1690-1704.

PMID: 38751113 PMC: 11213996. DOI: 10.1016/j.bpj.2024.05.012.


Brain Hydrophobic Peptides Antagonists of Neurotoxic Amyloid β Peptide Monomers/Oligomers-Protein Interactions.

Gutierrez-Merino C Int J Mol Sci. 2023; 24(18).

PMID: 37762148 PMC: 10531495. DOI: 10.3390/ijms241813846.


Ganglioside GM1 and the Central Nervous System.

Guo Z Int J Mol Sci. 2023; 24(11).

PMID: 37298512 PMC: 10253378. DOI: 10.3390/ijms24119558.


Lipid rafts and human diseases: why we need to target gangliosides.

Fantini J FEBS Open Bio. 2023; 13(9):1636-1650.

PMID: 37052878 PMC: 10476576. DOI: 10.1002/2211-5463.13612.


AmyP53 Prevents the Formation of Neurotoxic β-Amyloid Oligomers through an Unprecedent Mechanism of Interaction with Gangliosides: Insights for Alzheimer's Disease Therapy.

Azzaz F, Chahinian H, Yahi N, Fantini J, Di Scala C Int J Mol Sci. 2023; 24(2).

PMID: 36675271 PMC: 9864847. DOI: 10.3390/ijms24021760.